Healthcare & Life Sciences
Complex market dynamics and aging demographics create sustained healthcare demand
In the Healthcare & Life Sciences sector, it takes a highly focused approach to execute a transaction efficiently. The constant monitoring of new procedures, technology and product development, and overall market trends is required to stay on top of the healthcare industry. Our Healthcare & Life Sciences team brings this dedication and market knowledge to every transaction. CFI has significant transaction expertise in the medical device, biopharmaceutical, and health care sectors. CFI also has a proprietary healthcare consulting service offering which affords us a unique perspective into the industry. Our healthcare services include growth capital, targeted acquisition search, intellectual property / product line divestitures, and strategic sale advisory.
Our extensive sector knowledge and transaction experience span the following domains:
Cure & Care
Life Sciences
Medical Products
MedTech Devices
Outsourcing Services
Pharmacy
Our latest transactions
Healthcare & Life Sciences
has been acquired by
Transaction details
Hybrisan, a MedTech company founded to solve problems of bioburden and biofilm in healthcare, has been acquired by Eumar Technology
Healthcare & Life Sciences
has acquired the manufacturing operations of
Transaction details
Medical equipment manufacturing company CME Devices has acquired Creo Medical Group's manufacturing operations
Healthcare & Life Sciences
has completed the divestiture of its U.S.-based contract manufacturing and injection molding business unit to
Transaction details
Stevanato Group has completed the divestiture of Balda C. Brewer to Sage Park
Healthcare & Life Sciences
has sold a minority stake to
Transaction details
Turin-based radiological company Chiron Group has sold a minority stake to KYIP Capital, accelerating the Group’s expansion
Contact our experts
